Profound Medical Corp. (PROF) stock
PROFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$7.42−0.02 (-0.27%)
Close on Nov 13, 2026Market cap $271.07MP/E –Yield –
Profound Medical operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Profound Medical's operating cash flow for the twelve months ending Sep 30, 2026 was -$31.49M. For fiscal 2025 it was -$38.21M. The highest annual figure on record is -$15.05M in fiscal 2019.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$38.21M | – |
| FY2024 | Dec 31, 2024 | -$23.45M | – |
| FY2023 | Dec 31, 2023 | -$22.61M | – |
| FY2022 | Dec 31, 2022 | -$25.80M | – |
| FY2021 | Dec 31, 2021 | -$22.36M | – |
| FY2020 | Dec 31, 2020 | -$20.57M | – |
| FY2019 | Dec 31, 2019 | -$15.05M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$5.01M | – |
| Q2 FY2026 | Jun 30, 2026 | -$11.34M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.58M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.57M | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.61M | – |
| Q2 FY2025 | Jun 30, 2025 | -$13.74M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.28M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.88M | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.83M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.22M | – |
| Q1 FY2024 | Mar 31, 2024 | -$4.53M | – |
See a number that looks wrong?